Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>
P G Casali, A Le Cesne, A P Velasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G D Demetri, C R Antonescu, B Bjerkehagen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study
A Bonetti, V L Le, Z I Carrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2017
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
S Stacchiotti, A Gronchi, P Fossati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, S Bielack, N Abecassis, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>
P G Casali, A Le Cesne, A P Velasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2020
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G D Demetri, C R Antonescu, B Bjerkehagen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study
A Bonetti, V L Le, Z I Carrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2017
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
S Stacchiotti, A Gronchi, P Fossati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2018
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2018
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, N Abecassis, H T Aro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P G Casali, S Bielack, N Abecassis, et al.
Page
of 16